Quick Answer
Bone Biologics Corp reported Shares Outstanding of 1.80 million shares for fiscal year 2025.
Bone Biologics Corp Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 1.80M | +264.6% |
| 2024 | 492,417 | -7.8% |
| 2023 | 534,238 | +737.1% |
| 2022 | 63,820 | -99.4% |
| 2021 | 10.35M | -15.7% |
| 2020 | 12.27M | -60.0% |
| 2019 | 30.68M | +16.0% |
| 2018 | 26.45M | +511.1% |
| 2017 | 4.33M | -88.9% |
| 2016 | 38.83M | +20.5% |
| 2015 | 32.21M | +32.7% |
| 2014 | 24.27M | +122.1% |
| 2013 | 10.93M | +118.6% |
| 2013 | 5.00M | +0.0% |
| 2012 | 5.00M | +0.0% |
| 2011 | 5.00M | +0.0% |
| 2010 | 5.00M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 1.80M | -14.4% | +6.5% |
| June 30, 2025 | 1.69M | +28.1% | -48.5% |
| March 31, 2025 | 3.27M | +221.8% | +564.3% |
| December 31, 2024 | 492,417 | -7.8% | -76.5% |
| September 30, 2024 | 2.10M | -33.1% | +59.4% |
| June 30, 2024 | 1.32M | -58.0% | +29.4% |
| March 31, 2024 | 1.02M | -93.9% | +90.3% |
| December 31, 2023 | 534,238 | +4.7% | -83.0% |
- Bone Biologics Corp showed an increase of +264.6% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, Bone Biologics Corp’s shares outstanding has declined by 64.1% (from 5.00 million shares to 1.80 million shares).
- The most recent figure is from Bone Biologics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: